T. Singh

Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents

C. Woods, C. Lorang, T. Burke, 2021, medRxiv.

SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey

James. C. Squire, J. Kanu, O. Sankoh, 2021, BMJ Global Health.

The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior immunity, and assay conditions

E. Harris, L. Katzelnick, G. Kuan, 2023, medRxiv.

SARS-CoV-2 Novel Coronavirus: It’s Impact and Global Health Concerns

A. Singla, T. Singh, 2020 .

SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey

M. Vandi, James. C. Squire, A. Mounts, 2021, BMJ Global Health.